TY  - JOUR
AU  - Albert, N. L.
AU  - Weller, M.
AU  - Suchorska, B.
AU  - Galldiks, Norbert
AU  - Soffietti, R.
AU  - Kim, M. M.
AU  - La Fugére, C.
AU  - Pope, W.
AU  - Law, I.
AU  - Arbizu, J.
AU  - Chamberlain, M.
AU  - Vogelbaum, M. A.
AU  - Ellingson, B. M.
AU  - Tonn, J. C.
TI  - Response Assessment in Neuro-Oncology (RANO) Working Group and European Association for Neuro-Oncology (EANO): Recommendations for the Clinical Use of PET Imaging in Gliomas
JO  - Neuro-Oncology
VL  - 18
IS  - 9
SN  - 1522-8517
CY  - Oxford
PB  - Oxford Univ. Press
M1  - FZJ-2016-07679
SP  - 1199 - 1208
PY  - 2016
AB  - This guideline provides recommendations for the use of PET imaging in gliomas. The review examines established clinical benefit in glioma patients of PET using glucose (18F-FDG) and amino acid tracers (11C-MET, 18F-FET, and 18F-FDOPA). An increasing number of studies have been published on PET imaging in the setting of diagnosis, biopsy, and resection as well radiotherapy planning, treatment monitoring, and response assessment. Recommendations are based on evidence generated from studies which validated PET findings by histology or clinical course. This guideline emphasizes the clinical value of PET imaging with superiority of amino acid PET over glucose PET and provides a framework for the use of PET to assist in the management of patients with gliomas.
LB  - PUB:(DE-HGF)16
UR  - <Go to ISI:>//WOS:000384005900008
C6  - pmid:27106405
DO  - DOI:10.1093/neuonc/now058
UR  - https://juser.fz-juelich.de/record/825208
ER  -